1,2,4-Triazine Analogs as Novel Class of Therapeutic Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
14
Page:
168-207
Author(s):
Rajeev Kumar, T.S. Sirohi, Hariram Singh, Ramji Yadav, R.K. Roy, A. Chaudhary and S.N. Pandeya
Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
14
Page:
693-707
Author(s):
Jiong Cai and Fang Li
Design of Combretastatin A-4 Analogs as Tubulin Targeted Vascular Disrupting Agent with Special Emphasis on Their Cis-Restricted Isomers
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
1923-1955
Author(s):
Harish Rajak, Pramod Kumar Dewangan, Vijay Patel, Deepak Kumar Jain, Avineesh Singh, Ravichandran Veerasamy, Prabodh Chander Sharma and Anshuman Dixit
Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3805-3821
Author(s):
M. Sánchez-Hidalgo, J. M. Guerrero, I. Villegas, G. Packham and C. A. de la Lastra
The Role of Estrogen and Estrogen Receptors in Chemoresistance
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4674-4683
Author(s):
M. Sui, H. Zhang and W. Fan
Antisense Strategies in Therapy of Gliomas
Journal:
Current Signal Transduction Therapy
Volume:
6
Page:
411-423
Author(s):
Jerzy Trojan and Donald D. Anthony
Recent Studies on Macromolecular Synthesis Labeled with 3H-Thymidine in Various Organs as Revealed by Electron Microscopic Radioautography
Journal:
Current Radiopharmaceuticals
Volume:
2
Page:
118-128
Author(s):
Tetsuji Nagata
Synthetic and Natural Immunomodulators Acting as Interferon Inducers
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1238-1247
Author(s):
Dmytro S. Silin, Oksana V. Lyubomska, Feliks I. Ershov, Valeriy M. Frolov and Galyna A. Kutsyna
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
32-71
Author(s):
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento
“Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
3052-3061
Author(s):
Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Toshiaki Shirakata, Sumiyuki Nishida, Naoki Hosen, Hiroko Nakajima, Zheyu Li, Ichiro Kawase, Yusuke Oji and Haruo Sugiyama